During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium

Nature Medicine

Volumn 2, Issue 9, 1996, Pages 992-997

  Melder, Robert J ^a   Koenig, Gerald C ^a   Witwer, Brian P ^a   Safabakhsh, Nina ^a   Munn, Lance L ^a   Jain, Rakesh K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ADHESION; ENDOTHELIUM; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOKINE ACTIVATED KILLER CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

ANIMALS; CELL ADHESION; E-SELECTIN; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; KILLER CELLS, LYMPHOKINE-ACTIVATED; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; LYMPHOKINES; MICE; MICE, SCID; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; P-SELECTIN; TUMOR CELLS, CULTURED; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA;

EID: 0029793371     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0996-992     Document Type: Article

References (39)

1. Sasaki, A., Melder, R.J., Whiteside, T.L , Herberman, R B. & Jain, R K. Preferential localization of human adherent lymphokine-activated killer cells in tumor microcirculation J Natl. Cancer Inst. 53, 433-437 (1991).
2. Melder, R.J. et al. Imaging of activated natural killer (NK) cells in mice by position emission tomography (PET): Preferential uptake in tumors. Cancer Res. 53, 5867-5871 (1993)
3. Melder, R.J., Salehi, H.A & Jain, R.K. Localization of activated natural killer cells in MCaIV mammary carcinoma grown in cranial windows in C3H mice. Microvascular Res. 50, 35-44 (1995).
4. Melder, R.J., Walker, E., Herberman, R B. & Whiteside, T.L Adhesion characteristics of human interleukin 2-activated natural killer cells Cell Immunol 132, 177-192 (1991)
5. Allavena, P. et al Molecules and structures involved in the adhesion of natural killer cells to vascular endothelium. J. Exp. Med. 173, 439-448 (1991).
6. Melder, R.J., Munn, L L , Yamada, S., Ohkubo, C. & Jain, R K Selectin- and integrin-mediated T lymphocyte rolling and arrest on TNF-alpha-activated endothelium. Augmentation by erythrocytes. Biophys. J. 69, 2131-2138 (1995).
7. Jain, R.K. et al. Leukocyte-endothelial adhesion and angiogenesis in tumors. Cancer Metastasis Rev. 15, 195-204 (1996)
8. Munn, L.L., Melder, R.J. & Jain, R.K. Analysis of cell flux in the parallel plate flow chamber: Implications for cell capture studies. Biophys. J 67, 889-895 (1994).
9. Munn, L.L., Koenig, G.C., Jain, R.K. & Melder, R.J. Kinetics of adhesion molecule expression and spatial organization using targeted sampling fluorometry. BioTechniques 19, 622-631 (1995).
10. Yuan, F. et al. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res. 54, 4564-4568 (1994).
11. Jain, R.K. Determinants of tumor blood flow: A review. Cancer Res. 48, 2641-2648 (1988)
12. de Fourgerolles, A.R , Stacker, S A., Schwarting, R. & Springer, T.A. Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1 J. Exp. Med. 174, 253-267 (1991).
13. Folkman, J Tumor angiogenesis. in The Molecular Basis of Cancer (eds. Mendelson, J., Howley, P.M & Liotta, L A) 206-232 (Saunders, Philadelphia, 1995).
14. Fidler, I.J & Elis, L M. The implications of angiogenesis for biology and therapy of cancer metastasis. Cell 79, 185-188 (1994).
15. Jallal, B. et al. Suppression of tumor growth in vivo by local and systemic 90K level increase Cancer Res. 55, 3223-3227 (1995).
16. Dvorak, H.F., Brown, L.F., Detmar, M. & Dvorak, A.M Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146, 1029-1039 (1995).
17. Reed, J A., McNutt, N.S. & Albino, A.P. Differential expression of basic FGF (bFGF) in melanocytic lesions demonstrated by in situ hybridization: Implications for tumor progression. Am. J. Pathol. 144, 329-336 (1994).
18. Goto, F., Goto, K., Weidel, K. & Folkman, J. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. J. Lab. Invest. 69, 508-517 (1993).
19. Ferrara, N. Missing link in angiogenesis. Nature 376, 467 (1995).
20. Koch, A.E., Halloran, M.M , Haskell, C K , Shah, M R. & Polverini, P.J. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376, 517-519 (1995).
21. Friedlander, M. et al. Definition of two angiogenic pathways by distinct alpha v integrins. Science 270, 1500-1502 (1995).
22. Brooks, P.C et al Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157-1164 (1994).
23. Fukumura, D. et al. Tumor necrosis factor alpha-induced leukocyte adhesion in normal and tumor vessels: Effect of tumor type, transplantation site, and host strain. Cancer Res 55, 4824-4829 (1995).
24. Ohkubo, C., Bigos, D. & Jain, R.K. IL-2 induced leukocyte adhesion to the normal and tumor microvascular endothelium in vivo and its inhibition by dextran sulfate: Implications for vascular- leak syndrome. Cancer Res 51, 1561-1563 (1991).
25. Wu, N.Z , Klitzman, B., Dodge, R. & Dewhirst, M.W. Diminished leukocyte-endothelium interaction in tumor microvessels. Cancer Res. 52, 4265-4268 (1992).
26. Osborn, L. Leukocyte adhesion to endothelium in inflammation Cell 62, 3-6 (1990).
27. Gamble, J R., Khew-Goodall, Y. & Vadas, M A Transforming growth factor-beta inhibits E-selectin expression on human endothelial cells. J. Immunol. 150, 4494-4503 (1993)
28. Santambrogio, L. et al. Studies on the mechanisms by which transforming growth factor-beta protects against allergic encephalomyelitis. J Immunol. 151, 1116-1127 (1993).
29. + T cells. Proc. Natl. Acad. Sci. USA 91, 2890-2894 (1994).
30. Freeman, M.R et al. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: A potential role for T cells in angiogenesis Cancer Res. 55, 4140-4115 (1995).
31. Dellian, M., Witwer, B.P., Salehi, H.A., Yuan, F. & Jain, R. Quantitation and physiological characterization of angiogenic vessels in mice. Am. J. Pathol. 149, 59-71 (1996).
32. Melder, R.J & Jain, R.K. Kinetics of interleukin-2 induced changes in rigidity of human natural killer cells. Cell Biophys. 20, 161-176 (1992).
33. Sasaki, A., Jain, R.K , Maghazachi, A A., Goldfarb, R.H. & Herberman, R.B. Low deformability of lymphokine-activated killer cells as a possible determinant of in vivo distribution. Cancer Res. 49, 3742-3746 (1989).
34. Whiteside, T.L. & Goldfarb, R H. Antitumor effector cells: Extravasation and control of metastasis Immunol. Ser. 61, 159-173 (1994).
35. Melder, R J. et al. Cytotoxic activity against HIV infected monocytes by recombinant interleukin 2-activated natural killer cells AIDS Res. Hum. Retrovir. 6, 1011-1015 (1990).
36. Kitayama, J. et al. Lysis of endothelial cells by autologous lymphokine-activated killer cells. Cancer Immunol. Immunother. 38, 317-322 (1994).
37. Watson, C.A., Camera-Benson, L , Palmer-Crocker, R. & Pober, J.S. Variability among human umbilical vein endothelial cultures. Science 268, 447-448 (1995).
38. Gullino, P.M. Techniques in tumor pathophysiology. in Methods in Cancer Research (ed. Busch, II.) 45-92 (Academic Press, New York, 1970).
39. Melder, R.J., Whiteside, T L., Vujanovic, N.L , Hiserodt, J.C & Herberman, R.B A new approach to generating antitumor effectors for adoptive immunotherapy using human adherent lymphokine-activated killer cells Cancer Res. 48, 3461-3469 (1988).